Leontina Postelnicu

Credit: Nightingale Health/ European Investment Bank

January 22, 2019
Finnish biotech company Nightingale Health receives €20m financing from the European Investment Bank. Helsinki-headquartered Nightingale Health has secured a €20m loan from the European Investment Bank (EIB) to further develop its blood analysis technology and improve detection and prevention of chronic diseases. Nightingale’s metabolic profiling technology measures blood biomarkers - molecules...

Credit: Peak/ University of Cambridge

January 21, 2019
WHAT HAPPENED Researchers in the UK have designed a game that can improve users’ concentration, with a version being released today as part of the Peak Brain Training app for free. The team that developed and tested the game, called Decoder, from the University of Cambridge’s Behavioural and Clinical Neuroscience Institute have demonstrated that playing it for eight hours over a one-month period...
Man demonstrating math formula.
January 20, 2019
The European tech ecosystem saw record levels of investment in 2018, with the software industry growing five times faster than the rest of Europe’s economy, according to a report by global venture capital firm Atomico. Four tech IPOs or direct listings of European tech companies reached valuations of more than $5bn on opening day, and three of the top 10 largest tech IPOs in 2018 came from Europe...
January 16, 2019
Chronomics raises £1.12m in seed funding. Chronomics, a consumer epigenetic testing start-up founded in 2017, has secured £1.12m in seed funding, including investment from Anthemis and follow on funding from global venture capital firm SOSV. It has launched what it calls a “unique” epigenetic saliva testing kit that enables people to see how environmental and lifestyle factors, such as diet,...

HealthBeacon CEO and co-founder Jim Joyce; source: HealthBeacon

January 8, 2019
Dublin-headquartered digital therapeutics company HealthBeacon has closed a $12m Series A investment round to fuel its push into the US, Canada and UK markets. The company, which develops smart tools to manage medication, made the announcement at the JP Morgan Digital Medicine and Medtech Showcase in San Francisco this week. Its smart sharps bin solution aims to help patients who self-inject...
January 7, 2019
Researchers in the UK have launched a clinical trial to see if a breath test device could detect the presence of cancer at an early stage.  They aim to collect and analyse breath samples from 1,500 participants at Addenbrooke’s Hospital in Cambridge over the next two years to see if odorous molecules called volatile organic compounds (VOCs) can be detected by using the Breath Biopsy technology of...
NHS hospital sign.
January 7, 2019
Digitally-enabled care is expected to become a "mainstream part" of the NHS in England under a 10-year plan unveiled today.
January 7, 2019
A blueprint that will be published by NHS leaders later today could help save up to half a million more lives in England through a "renewed" focus on prevention, cutting edge treatments, and the use of new forms of technology, NHS England has said. The development of a long-term plan follows a five-year funding settlement unveiled by Prime Minister Theresa May last year, with the NHS set to...
December 13, 2018
Galway, Ireland-headquartered WhiteSwell has closed a $30m series B funding round to support a pivotal trial and advance the development of its therapy system for the treatment of acute decompensated heart failure (ADHF). Heart failure occurs when the heart is not pumping enough blood to meet the needs of the body, with main symptoms including shortness of breath and feeling unusually tired,...

Novo Nordisk opened a new research centre in Oxford, UK earlier this year, located on the third floor of a new building at Oxford University; illustration: Novo Nordisk

December 12, 2018
Oxford, UK-based e-therapeutics has announced this week that it is entering a research partnership with Novo Nordisk that will see them use its proprietary Network-Driven Drug Discovery (NDD) platform to identify potentially new biological mechanisms and therapies for a “specific area” of type 2 diabetes. According to the International Diabetes Federation, around 425 million people are estimated...